-
Most Recent
Search Results
240 results for icgn
Why Is Ocugen (OCGN) Stock Up 5% Today?
Ocugen stock is rising higher on Tuesday thanks to OCGN investors celebrating news of a new clinical trial for its Covid-19 vaccine.
Why Is Ocugen (OCGN) Stock Climbing Higher Today?
Ocugen (OCGN) stock is gaining on Tuesday after Mizuho Securities analysts initiated coverage of the medical company’s shares.
Solid Earnings Growth Keep Icon (ICLR) a Buy
Currently, Icon Plc (NASDAQ:ICLR) has a Buy using the approach to investing of Louis Navellier and his Portfolio Grader stock evaluator. ICLR has maintained this…
Icon Plc (ICLR) Stock is Cultivating a Strong Business
Icon Plc has seen strong growth since its inception in 1990, and ICLR stock is promising, if still a little risky.
Icon (ICLR) Raised to Strong Buy from a Buy
Icon Plc (NASDAQ:ICLR) ranks in the upper half of its industry group, Life Sciences Tools & Services, and in the top 25% of its sector…
5 Stephen Hawking Quotes to Remember the Iconic Physicist
Stephen Hawking passed away early on Wednesday morning while at his home in Cambridge and ‘InvestorPlace’ is remembering him with some quotes.
Iconic Luxury Retailer Henri Bendel Closing for Good
Henri Bendel, a luxury retailer based in NYC, is closing its doors for good as owner L Brands (LB) looks to save some money.
Ringling Brothers Circus to Phase Out Iconic Elephants
The Ringling Brothers Circus, announced on Thursday, that it won’t have elephant acts by 2018 as it phases the animals out of its shows.
Can Pat Toomey Save Ocugen (OCGN) Stock?
Shares of OCGN stock received a boost this morning following the addition of some high-profile names to Ocugen’s advisory board.
The Reasons to Avoid OCGN Stock Keep Piling Up
OCGN stock got a bump on Phase 3 results but was met with market skepticism following its subsequent strategic moves.
3 Iconic American Brands Destined for the Trash Heap
The economic downturn — and in some cases, just good, old-fashioned obsolescence — is taking a toll on these three American mainstays.
How Buffett & 6 Other Icons Fared in 2010
Who had a better year on Wall Street — Warren Buffett, Carl Icahn or Jim Cramer?
Why This Iconic Glass Company Is a Great AI Play
If we were to play a word-association game and I said, “Artificial intelligence,” you might respond with something like “Nvidia,” or “Google.” Maybe even, “Robots.”…
Why This Iconic Glass Company Is a Great AI Play
In yesterday’s Market 360, we talked briefly about entering Phase 2 of the AI Revolution thanks to quantum computing. Today, I want to share a great…
Why Is Ocugen (OCGN) Stock Up 7% Today?
Ocugen is returning to its eye treatment roots after a brief life as a Covid-19 vaccine meme stock in 2021 delivered OCGN stock no results.
Why Is Ocugen (OCGN) Stock Up 20% Today?
Ocugen stock is heading higher on Friday as investors in OCGN shares react to a dismissed class action lawsuit against the company.
Why You Should Keep Your Distance from Ocugen Stock
Off and on the price chart OCGN stock, today’s reality is bleak for shareholders, but being a bear poses its own challenges.
Don’t Play the Ocugen Stock Short Squeeze Before You Read This Warning!
While the contrarian bullish argument for OCGN stock has picked up considerable chatter, this is an extremely risky trade.
Entry Into Infectious Disease Field Creates Opportunity for Ocugen
Now that Ocugen is collaborating to develop a Covid-19 vaccine, OCGN stock holders should brace for a possible regulatory authorization.
The Vaccine Deal Boost Can’t Keep Ocugen Stock Afloat
No one wants to be the bearer of bad news, but we must acknowledge that the vertical move in OCGN stock is turning out to…
Is Ocugen Worth a Shot Because of the Worsening Pandemic?
While OCGN stock seems like a reasonable speculation based on the worsening Covid-19 crisis, it’s still a tough gamble.
Ocugen Has a Longer Road To Paying off Than People Think
Ocugen seems to have delivered good news in recent days, yet OCGN stock is right back where it started. Does that create a buying opportunity?
Despite an 80% Drop, Ocugen Stock Is Still Too Pricey
Until the hype surrounding its Covid-19 vaccine candidate is no longer priced into shares, it’s best to avoid OCGN stock.
3 – 10 of 240 results
